TIL Therapies market Share, Growth Analysis by 2035 | # TIL-based therapies # Tumor Infiltrating Lymphocyte Receptor # TIL # Market Research # Market Insights

TIL Therapies market Share, Growth Analysis by 2035 | # TIL-based therapies # Tumor Infiltrating Lymphocyte Receptor # TIL # Market Research # Market Insights

Latest news on Organ on a Chip market Research Report by 2035

In order to overcome the limitations and challenges related to animal testing, researchers and industry stakeholders are gradually adopting organ-on-chip products and technologies, which offer multiple benefits over conventional systems

Roots Analysis has announced the addition of “Organ-on-Chip Market, 2022-2035: Focus on Products and Technologies” report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of organ-on-chip products and technologies, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
 A general introduction of organ-on-chip, including history and development, classification, advantages and limitations and applications and future perspectives of organ-on-chip.
 A detailed assessment of the current market landscape of organ-on-chip products and technologies based on a number of relevant parameters, such as type of offering(s) (chip, plate / system, and technology), type of model(s) (organ(s) based and disease(s) based), status of development (commercialized, developed, and under development), type of technology / platform, number of chips in a plate, material used for construction of chip / plate (polymer, glass and silicon), type of polymer (polydimethylsiloxane, cyclic olefin polymer, cyclic olefin copolymer, elastomer, polycarbonate, polypropylene, polystyrene, polyester, tygon, and styrene TEP), compatible tissue / organ, and application area (cancer research, drug discovery and toxicity testing, stem cell research, and tissue engineering and regenerative medicine). In addition, the chapter provides details on the companies engaged in the development of organ-on-chip products and technologies, along with information on their year of establishment, company size and location of headquarters.
 Elaborate profiles of the key players developing organ-on-chip products and technologies (which are presently commercialized), which are headquartered in North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, organ-on-chip product portfolio, recent developments, and an informed future outlook.
 An in-depth analysis of various patents that have been filed / granted for organ-on-chip, till 2022, based on various relevant parameters, such as type of patent, publication year, application year, issuing authorities involved, type of organizations, emerging focus area, patent age, CPC symbols, leading patent assignees (in terms of number of patents granted / filed), patent characteristics and geography. It also includes an insightful patent valuation analysis.
 A detailed brand positioning analysis of the key industry players, highlighting the current perceptions regarding their proprietary products by taking into consideration several relevant aspects, such as experience of the manufacturer, number of products and technologies offered, product diversity, and number of patents published.
 A study of the various grants that have been awarded to research institutes engaged in projects related to organ-on-chip, between 2017 and 2022, based on parameters, such as year of award, support period, amount awarded, funding institute center, grant type, emerging focus area, type of recipient organization, key regions, and leading recipient organizations.
 An analysis of the partnerships that have been established since 2017, covering various types of partnerships, such as product / technology utilization agreements, licensing agreements, research and development agreements,, and commercialization agreements, , and of the companies focused on developing organ-on-chip products and technologies.
 An analysis of the investments made, including seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings, at various stages of development in start-ups / small companies (with less than 50 employees) and mid-sized companies (with 51-200 employees) that are focused on developing organ-on-chip products and technologies.
 A case study on scaffold-free 3D cell culture products, including hanging drop plate, 3D petri dish, and ultra-low attachment plate, featuring a list of more than 60 products that are being used for research and pharmaceutical testing, based on a number of relevant parameters, such as status of development (commercialized and developed, not commercialized), type of system (suspension system, attachment resistant and microfluidic system), type of product (ultra-low attachment plate, plate, hanging drop plate, chips and dish) and material used for fabrication (chemical / polymer based, human based and plant based).

By 2035, The financial opportunity within the organ-on-chip market has been analyzed across the following segments:
 Type of Product
 Organ(s) based
 Disease(s) based

 Type of Application Area
 Drug Discovery and Toxicity Testing
 Cancer Research
 Tissue Engineering and Regenerative Medicine
 Stem Cell Research

 Purpose
 Research Use
 Therapy Development

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World (RoW)

Key Companies covered in the report
 BEOnChip
 Dynamic42
 Emulate
 MIMETAS
 SynVivo
 TissUse
 uFluidix

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/organ-on-a-c

You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market

Global Antibiotics Market


You may also like to learn what our experts are sharing in Roots educational series:
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Rare Kidney Disorders: Future Miracle Drugs


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#organonchipproductsandtechnologies #organonachipmodels #organonachipmarket #organonachipmarketsize

Genotoxicity Testing market Growth Analysis by 2035

The “Genotoxicity / Mutagenicity Testing Services Market, 2023-2035” report features an extensive study of the current landscape and the likely future potential of genotoxicity and mutagenicity testing, over the next decade

Key Inclusions
 A detailed review of the overall market landscape of genotoxicity and mutagenicity testing service, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, type of organization, location of the facility, type of operation (genotoxicity and mutagenicity), type of offering (service, and reagents and consumables), type of assay(s) (in vitro, in vivo and non-GLP / Screening), assay(s) / test(s) offered (Ames test, micronucleus test, chromosomal aberration test, genetic mutation assay, comet assay and others), end user industry (healthcare industry, chemical industry, agriculture industry, cosmetic industry, food industry and other industries) and type of testing system(s) (bacteria, animals and novel technology)
 An insightful benchmark analysis of various service providers segregated into three peer groups, based on location of their headquarters (North America, Europe, and Asia-Pacific), highlighting the top players in this domain, based on their respective capabilities.
 An elaborate profile of genotoxicity and mutagenicity service providers. Each profile includes a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.
 An in-depth analysis of various publications related to genotoxicity and mutagenicity, based on several relevant parameters, such as year of publication, type of article, popular publishers (in terms of number of publications), popular journals (in terms of number of number of publications), journal impact factor and popular journals (in terms of journal impact factor). It also highlights a publication timeline analysis (by article type and journal impact factor), along with the benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area.
 A detailed review of academic grants that have been awarded to various research institutes for projects focused on genotoxicity and mutagenicity, since 2018, based on several parameters, such as year of grant award, amount awarded, funding institute center, administering institute center, support period, purpose of grant, activity code, type of recipient organization, location of recipient organization, study section involved, type of grant application and popular NIH departments (in terms of number of grants). Further, the chapter also highlights the prominent program officers (in terms of number of grants) and popular recipient organizations (in terms of number of grants).
 An in-depth analysis of the various collaborations and partnership agreements that have been inked by stakeholders engaged in this domain, during the period 2018-2022. It includes a brief description of the partnership models (including acquisitions, platform licensing, service alliances, mergers and platform development and commercialization) adopted by stakeholders in this domain. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, analysis on most active players and regional analysis. Further, the chapter includes a world map representation of all the deals inked in this field in the period 2018-2022, highlighting both intercontinental and intracontinental agreements.
 An in-depth analysis of various patents that have been filed / granted related to genotoxicity and mutagenicity, since 2018, taking into consideration parameters, such as type of patent, publication year, geographical region, CPC symbols, leading players (in terms of number of patents filled / granted) and type of applicant. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
an insightful market forecast analysis, highlighting the likely growth of the genotoxicity and mutagenicity testing service market till the year 2035. In order to provide details on the future opportunity. Further, our projections have been segmented based on relevant parameters, such as type of assay (in vivo, in vitro and non-GLP / screening), assay / test offered (comet assay, micronucleus assay, chromosomal aberration test, genetic mutation test and others), end user industry (chemical industry, healthcare industry, agriculture industry, cosmetic industry and other industries) and key geographical regions (North America, Europe, Asia- Pacific, Latin America, and Middle East and North Africa).

The financial opportunity within the adeno-associated viral vector market has been analyzed across the following segments:
 Type of Assay
 In vivo Assays
 In vitro Assays
 Non-GLP / Screening Assays

 Assay / Test Offered
 Comet Assays
 Micronucleus Assays
 Chromosomal Aberration Tests
 Genetic Mutation Tests
 Other Tests

 End User Industry
 Chemical Industry
 Healthcare Industry
 Agriculture Industry
 Cosmetic Industry
 Other Industries

 Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 MENA

The research also includes detailed profiles of the key players (listed below) engaged in the adeno-associated viral vector market; each profile features an overview of the company, its financial information (if available), details related to its manufacturing facilities and proprietary vector manufacturing technology portfolio, and recent developments and an informed future outlook.
 Aurigene Pharmaceutical Services
 Charles River Laboratories
 GLR Laboratories
 Labcorp
 LSIM Safety Institute
 Sai Life Sciences
 Syngene

Key Questions Answered
 What is genotoxicity and mutagenicity?
 What are the key advantages offered by genotoxicity and mutagenicity testing?
 Which companies offer genotoxicity and mutagenicity testing services?
 What is the need for outsourcing genotoxicity / mutagenicity testing to contract service providers?
 How many grants have been offered for genotoxicity / mutagenicity testing?
 What is the trend of publications related to genotoxicity / mutagenicity testing?
 Across which key industries can genotoxicity / mutagenicity testing be utilized?
 What is the market size of genotoxicity / mutagenicity testing services?

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/genotoxicity

You may also be interested in the following titles:
Lab Automation Market

Cannabis Testing Market



About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#genotoxicitytestingmarket #genotoxicitytestingmarketsize #mutagenicity #genetictoxicology #genotoxicity testing

Medical Device Coatings market Trends, Analysis by 2035

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

Roots Analysis has announced the addition of “Medical Device Coatings Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the medical device coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.


Amongst other elements, the report includes:
 A detailed executive summary of the insights captured during our research.
 A detailed assessment of the current market landscape of medical device coating providers.
 Detailed competitiveness analysis of various medical device coating providers.
 A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.
 Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.
 An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.
 An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices
 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings
 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large
 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/medical-devi

You may also be interested in the following titles:
Cell Therapy Manufacturing Market
Global TCR Therapy Market


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

Medical Device Coatings market, Medical Device Coatings market Growth, Medical Device Coatings, antimicrobial coatings for medical devices, surface treatment technologies